CN112342214A - sgRNA sequence for targeted knockout of channel catfish zbtb38 gene and screening method thereof - Google Patents
sgRNA sequence for targeted knockout of channel catfish zbtb38 gene and screening method thereof Download PDFInfo
- Publication number
- CN112342214A CN112342214A CN202011253224.5A CN202011253224A CN112342214A CN 112342214 A CN112342214 A CN 112342214A CN 202011253224 A CN202011253224 A CN 202011253224A CN 112342214 A CN112342214 A CN 112342214A
- Authority
- CN
- China
- Prior art keywords
- zbtb38
- sgrna
- sequence
- gene
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 64
- 108091027544 Subgenomic mRNA Proteins 0.000 title claims abstract description 55
- 241000252498 Ictalurus punctatus Species 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000012216 screening Methods 0.000 title claims abstract description 20
- 108091033409 CRISPR Proteins 0.000 claims abstract description 18
- 238000000338 in vitro Methods 0.000 claims abstract description 18
- 238000013518 transcription Methods 0.000 claims abstract description 18
- 230000035897 transcription Effects 0.000 claims abstract description 18
- 241000252212 Danio rerio Species 0.000 claims abstract description 14
- 238000012408 PCR amplification Methods 0.000 claims abstract description 14
- 239000013612 plasmid Substances 0.000 claims abstract description 13
- 238000000520 microinjection Methods 0.000 claims abstract description 5
- 238000010354 CRISPR gene editing Methods 0.000 claims abstract 6
- 239000012634 fragment Substances 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 8
- 238000010367 cloning Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 2
- 235000013601 eggs Nutrition 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000004458 analytical method Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 42
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 31
- 239000000047 product Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000001962 electrophoresis Methods 0.000 description 11
- 238000012163 sequencing technique Methods 0.000 description 9
- 101710163270 Nuclease Proteins 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- 101000916547 Homo sapiens Zinc finger and BTB domain-containing protein 38 Proteins 0.000 description 4
- 102100028125 Zinc finger and BTB domain-containing protein 38 Human genes 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000010453 CRISPR/Cas method Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 108020005004 Guide RNA Proteins 0.000 description 2
- 102000025443 POZ domain binding proteins Human genes 0.000 description 2
- 108091014659 POZ domain binding proteins Proteins 0.000 description 2
- 101710137500 T7 RNA polymerase Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 101150038500 cas9 gene Proteins 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 241000203069 Archaea Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 102000008836 BTB/POZ domains Human genes 0.000 description 1
- 108050000749 BTB/POZ domains Proteins 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 108091028113 Trans-activating crRNA Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 239000013636 protein dimer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Abstract
The invention provides a sgRNA sequence for targeted knockout of channel catfish zbtb38 gene and a screening method thereof, wherein a CRISPR sequence is designed, a PCR amplification product containing a target gene is prepared and connected with a vector, then the sgRNA is prepared by an in vitro transcription method, the sgRNA, a plasmid containing the target gene and a Cas9 protein are subjected to microinjection into a zebra fish fertilized egg, and the zebra fish fertilized egg is used as a reactor to screen the sgRNA sequence for targeted knockout of channel catfish zbtb38 gene. The method takes the zebra fish fertilized eggs as a reactor to screen out the sgRNA sequence of the edited ictalurus punctatus zbtb38 gene for the first time, has strong specificity and high knockout efficiency, has simple and quick knockout process, and provides animal materials for the subsequent analysis of the function of the ictalurus punctatus zbtb38 gene.
Description
Technical Field
The invention relates to the field of genetic engineering, in particular to the technical field of preparation of channel catfish mutants, and particularly relates to a sgRNA sequence for targeted knockout of channel catfish zbtb38 gene and a screening method thereof.
Background
The CRISPR/Cas system is an acquired immune defense system present in bacteria and archaea, which leaves foreign gene fragments as "memory antibodies" in the self genome to recognize re-invading viruses when bacteria are infected with viruses. The CRISPR/Cas system consists of CRISPR (clustered regulated short palindromic repeats) elements consisting of multiple identical repeats (repeats) alternating with different spacers (spacers) and genes encoding a range of Cas proteins. CRISPR/Cas9 is the most widely used type of CRISPR/Cas system, the Cas protein is composed of a single Cas9 protein, and the main function of Cas9 protein depends on: (1) cas9 needs crRNA and trans-activating RNA (tracrRNA) to guide the target sequence together in bacteria, and two RNA molecules have been properly modified in the existing genetic engineering, and the sequence is integrated into a single-stranded guide RNA (sgRNA); (2) cas9 specifically recognizes a base pair of 3-7 bp at the 3' end of the target DNA, namely a PAM (promoter adjacent motif) region. Now, because the gRNA is convenient to design and synthesize, and the system has high efficiency on the knockout efficiency of the target gene, the CRISPR/Cas9 system is widely applied to genetic modification of cells and animal models.
ZBTB38, also known as CIBZ, ZNF921 or PPP1R171, belongs to a ZBTB protein family (zinc finger and BTB domain-containing protein family) member, contains a BTB domain of about 1 amino acid at the N-terminus and a plurality of zinc finger domains at the C-terminus. The zinc finger structure at the C end of the protein family has the function of recognizing a fixed cis-acting element or combining with a DNA methylation site, and the BTB structural domain at the N end generally mediates the formation of homologous or heterologous protein-protein dimers or multimers, so that the chromatin structure is changed, and the function of gene transcription regulation is achieved. Some members of the ZBTB protein family have been shown to play important roles in a variety of biological processes including spermatogenesis, sex determination, nerve and organ development, tumorigenesis, and the like. In earlier researches, a plurality of sex-linked SNP sites exist on the channel catfish zbtb38 gene, and the channel catfish is supposed to play a certain role in the process of determining the sex of the channel catfish. How to effectively edit the channel catfish zbtb38 gene by using CRISPR/Cas9 is a technical problem to be solved.
Disclosure of Invention
The purpose of the invention is as follows: in order to overcome the defects in the prior art, the invention provides an sgRNA sequence for targeted knockout of channel catfish zbtb38 gene and a screening method thereof.
The technical scheme is as follows: in order to achieve the purpose, the invention provides a screening method of a sgRNA sequence for targeted knockout of channel catfish zbtb38 gene, which comprises the steps of designing a CRISPR sequence, wherein the CRISPR sequence is shown as a sequence SEQ NO. 1-SEQ NO. 8; preparing a PCR amplification product containing a target gene fragment by using the CRISPR sequence, wherein the target gene fragment is shown as a sequence SEQ NO. 9; connecting the PCR amplification product containing the target gene fragment with a vector, transforming, screening positive transformants, cloning and shaking bacteria, and extracting a plasmid containing a target gene; preparing sgRNA by adopting an in vitro transcription method according to the designed CRISPR sequence; and (3) microinjecting the sgRNA, the plasmid containing the target gene and the Cas9 protein into a fertilized egg of the zebra fish, and screening and editing the sgRNA sequence of the channel catfish zbtb38 gene by using the fertilized egg of the zebra fish as a reactor.
Preferably, the CRISPR sequence is located 393bp before exon zbtb38 of the gene.
Preferably, the sequence of the sgRNA includes one or more of the sequences shown in SEQ NO. 21-SEQ NO. 28.
Preferably, the sgRNA is prepared by an in vitro transcription method, and the used forward primer sequence comprises one or more of sequences shown as SEQ NO. 12-SEQ NO. 19.
Preferably, the plasmid containing the target gene is extracted by cloning and shaking the bacteria, and the primer sequence used by the plasmid comprises one or more of the sequences shown in SEQ NO.10 and SEQ NO. 11.
Preferably, the plasmid containing the target gene is extracted by cloning and shaking the strain, and the used vector is pGEM-T Easy vector.
Preferably, the microinjection uses the sgRNA at a final concentration of 100ng/μ L in the injection solution and the Cas9 protein at a final concentration of 250ng/μ L.
As another aspect of the invention, the invention provides a sequence for targeted knockout of channel catfish zbtb38 gene, which comprises CRISPR sequence shown as sequence SEQ No. 7; the primer comprises one or more than one of the sequences shown in SEQ NO. 10-SEQ NO. 20; the sgRNA sequence comprises one or more sequences shown in SEQ NO. 21-SEQ NO. 28.
The invention has the following beneficial effects:
according to the invention, the sgRNA sequence for effectively editing the zbtb38 gene is screened out from the channel catfish, the sgRNA prepared according to the screened CRISPR sequence has strong specificity and high knockout efficiency, the knockout process is simple and quick, and animal materials can be provided for the subsequent analysis of the channel catfish zbtb38 gene function.
Drawings
FIG. 1 is a diagram showing the result of electrophoresis of amplified target genomic DNA fragments;
fig. 2 is a graph showing the electrophoresis results of the sgRNA in vitro transcription template after purification;
FIG. 3 is a diagram of mass electrophoretic identification results of sgRNAs prepared by in vitro synthesis;
FIG. 4 is a diagram showing the electrophoresis results of PCR amplification products identified by the gene knockout efficiency of zbtb 38;
fig. 5 is a typical peak of CRISPR2 for mutation detection;
fig. 6 is a typical peak of CRISPR7 for mutation detection.
Detailed Description
The present invention will be further described with reference to the accompanying drawings.
Example 1: CRISPR sequence design
1. Designing a targeting site
The genomic sequence of channel catfish zbtb38 is obtained from NCBI database, 8 CRISPR sequences are designed on the region before 393bp of exon in the experiment, and active CRISPR screening is carried out. The CRISPR design of the zbtb38 gene adopts an artificial method, and the candidate off-target prediction is realized by comparing a CRISPR sequence with a channel catfish genome sequence in GenBank through BLAST.
Table 1 CRISPR sequences designed based on the zbtb38 gene
2. PCR amplification of target genomic DNA fragments
1) The target genome sequence is shown as SEQ NO. 9:
ATGATGGTGGTCCATTCCAGCTGCAATGGGATGATGGACAACTTGCACCCCCACACTGTTCTTTCTCGACTCAGCGAACAACGATCACTTGGCCTGTTCTGTGATGTTACCATTGTTGTGGAGGACATCAAATTCCGTGCTCACAGAAATGTCTTGGCTGCGACTAGCGGATATTTCCGCAACGCTTTCACAGCCTCTGAGACTTGTGGTTCCAGCCAGGTGCTGGAAATTCCAGATCTCAAGTCAGAGGTGTTTGCCAGCATCCTTAATTTCATTTACTCCTCCAAAGTGGATTTAGCAAGTAAAGGGGACAACAAGTCCTTAATAGCTGCAGGGAAAAGGTTAGGGATCCCCTTTCTTGAGAAACTTCTTGAGATTGAAAGGCAAGACTCT。
2) primer design for PCR amplification
TABLE 2 amplification primers for the zbtb38 gene fragment
Sequence name | Sequence of | Use of | Numbering |
zbtb38-F1 | CAATGGGATGATGGACAACT | Forward outer primer | SEQ NO.10 |
zbtb38-R1 | AGTCTTGCCTTTCAATCTCA | Reverse outer primer | SEQ NO.11 |
3) PCR reaction system and conditions
The PCR reaction system (40. mu.L) was: 2 XMastermix (Novozan) 20. mu.L, 16. mu.L of ultrapure water, 1. mu.L of forward and reverse (zbtb38-F1, zbtb38-R1) primers (5. mu.M), and 2. mu.L of channel catfish target genomic DNA template.
The conditions of the PCR reaction were: 96 deg.C for 3min, 35 × (96 deg.C for 30s,60 deg.C for 30s,72 deg.C for 30s), 72 deg.C for 10min, and 4 deg.C.
The electrophoresis result of the amplified DNA fragment containing the target gene is shown in FIG. 1. Lane 2 from left to right is DNA Marker: 100bp, 250bp, 500bp, 750bp, 1000bp, 2000bp, 3000bp and 5000bp are sequentially arranged from bottom to top; lane 1 is the PCR lateral amplification product.
4) PCR product recovery
The PCR product was recovered using a PCR clean up (Axygen) kit without nuclease contamination. Mixing 38 mu L of PCR outside amplification product with 114 mu L of Buffer PCR-A without nuclease pollution, placing the mixture on a recovery column, centrifuging for 1min, discarding waste liquid, adding Buffer W2, 12,000g, centrifuging for 1min, discarding waste liquid, repeating the step, discarding waste liquid, 12,000g, air-throwing and centrifuging for 1min, finally adding DEPC water (Nagjingguoshuyu biology company) with no nuclease pollution as a recovery solvent, wherein the recovery volume is 30 mu L.
5) Ligation of PCR amplification products of target genes
The recovered PCR amplification product was ligated into pGEM-T Easy vector (5. mu.L total volume reaction) consisting of:
the reaction time is as follows: incubating at room temperature for 60min
6) Transformation of
mu.L of the ligation product was transformed with 50. mu.L of E.coli DH 5. alpha. competent cells (pfu. gtoreq.108). Then, the plate was plated on LB plate containing ampicillin (50. mu.g/mL) and cultured overnight at 37 ℃ in an inverted state.
7) Recombinant screening of target Gene fragments
(1) And (3) rapidly preparing a PCR template: the plates were plated and 8 clones were randomly picked each with a 10. mu.L sterile tip. The samples were placed in PCR 8 tubes containing 20. mu.L of liquid LB, and mixed by hand quickly to serve as a template for PCR.
(2) PCR verification system reaction composition
A first reaction system:
and (2) reaction system II:
(3) and (3) PCR reaction conditions:
95 ℃ for 3min, 35 × (95 ℃ for 30s,56 ℃ for 30s,72 ℃ for 40s), 72 ℃ for 10min, and 4 ℃ for storage.
(4) Sequencing of transformants
After the above PCR verification, the positive transformants were sequenced by a commercial company, and 3 correct clones were obtained by sequencing primer T7, one of the clones was selected and shaken and extracted to obtain a plasmid (concentration 224 ng/. mu.L, OD value: 1.93).
Example 2: sgRNA in vitro transcription
1. Preparation of sgRNA template (PCR method)
The forward primer sequences are shown in Table 2 below:
TABLE 3 Forward primer sequences
Note: the underlined sequence indicates the T7 promoter.
Reverse primer R-Common: AAAAAAAGCACCGACTCGGTGCCAC, SEQ No. 20.
PCR reaction (80. mu.L): 2 XMastermix (Novozan) 40. mu.L, 35. mu.L of ultrapure water, 2. mu.L of forward (zbtb38-sgRNA (1 to 8) -F and R-Common, respectively) primer (5. mu.M) and 1. mu.L of pYSY-sgRNA plasmid (Nanjing Yashunity Bio, 10 ng/. mu.L).
And (3) PCR reaction conditions: 95 ℃ for 3min, 35 × (95 ℃ for 30s,56 ℃ for 30s,72 ℃ for 30s), 72 ℃ for 10min, and 4 ℃ for storage.
2. Purification of sgRNA in vitro transcription template
The PCR product was recovered using a PCR clean up (Axygen) kit without nuclease contamination. The recovery solvent was ultrapure water without nuclease contamination, and the recovery volume was 14. mu.L each. mu.L of each sample was subjected to agarose gel electrophoresis (1%) and the recovery quality was checked. The electrophoresis result of the purified sgRNA in vitro transcription template is shown in fig. 2. Lane 9 from left to right is DNA Marker: 100bp, 250bp, 500bp, 750bp, 1000bp, 2000bp, 3000bp and 5000bp are sequentially arranged from bottom to top; lanes 1-8 are in vitro transcription templates of the sgRNAs purified from zbtb 38-sgRNAs 1-8.
3. In vitro transcription of sgRNA
1) In vitro transcription process
The obtained purified sgRNA in vitro transcription template is subjected to in vitro transcription with T7 RNA polymerase. Using an RNA in vitro Transcription kit (MAXiScript SP6/T7, Ambion, USA), 10 × Transcription Buffer 2 μ L, 10mM ATP 1 μ L, 10mM CTP 1 μ L, 10mM GTP 1 μ L, 10mM UTP 1 μ L, T7 RNA polymerase mix 2 μ L, and template DNA 12 μ L were added in this order according to the kit instructions, gently mixed, centrifuged, and then subjected to 37 ℃ water bath for 1 h.
2) Electrophoretic identification of sgRNA quality
mu.L of each sample was subjected to agarose gel electrophoresis (1%) to determine the integrity, and the results were as follows: the quality electrophoresis identification result of sgRNA prepared by in vitro synthesis is shown in figure 3. Lane 9 from left to right in the figure is a DNA Marker: 100bp, 250bp, 500bp, 750bp, 1000bp, 2000bp, 3000bp and 5000bp are sequentially arranged from bottom to top; lanes 1 to 8 are zbtb38-sgRNA1 to 8 in this order.
Table 4 sgRNA concentration measurement results
(Nano Drop)sgRNA | Concentration (ng/. mu.L) | OD(260/280) |
zbtb38-sgRNAI | 810 | 1.92 |
zbtb38-sgRNA2 | 843 | 1.81 |
zbtb38-sgRNA3 | 875 | 1.81 |
zbtb38-sgRNA4 | 902 | 1.89 |
zbtb38-sgRNA5 | 813 | 1.85 |
zbtb38-sgRNA6 | 784 | 1.95 |
zbtb38-sgRNA7 | 896 | 1.95 |
zbtb38-sgRNA8 | 841 | 1.98 |
TABLE 5 sgRNA sequences
Example 3: microinjection of zebra fish fertilized eggs
1. Collecting fertilized eggs of zebra fish by a conventional method. The sgRNA is divided into odd groups (1, 3, 5 and 7) and even groups (2, 4, 6 and 8) (the final concentration is about 100 ng/mu L), and respectively mixed with a plasmid (the final concentration is about 50 ng/mu L) containing a channel catfish zbtb38 target gene fragment and Cas9 protein (the final concentration is 200 ng/mu L), and then injected into zebrafish fertilized eggs in a micro-injection amount of 1nL per embryo.
2. Extracting zebra fish embryo DNA: when the zebra fish embryos are injected to 24hpf, 16 embryos in odd and even groups are respectively taken to prepare genome DNA templates (32 embryo samples in total), and the genome DNA templates are prepared by using a zebra fish genotype identification kit, wherein the specific reaction conditions are as follows: 30min at 65 deg.C, 5min at 95 deg.C, 1min at 16 deg.C, and 4 deg.C.
3. PCR amplification reaction System (30. mu.L)
And (3) PCR system: 2 XMASTERMIx (Vazyme) 15. mu.L, 11. mu.L of ultrapure water, 1. mu.L of forward and reverse (zbtb38-F1 and zbtb38-R1) primers (5. mu.M), and 2. mu.L of genomic DNA template prepared from 3.4.1.
The PCR reaction conditions are as follows: 95 deg.C for 3min, 30 × (95 deg.C for 30s,60 deg.C for 30s,72 deg.C for 30s), 72 deg.C for 10min, and 4 deg.C.
4. Electrophoresis results of PCR products
mu.L of each was subjected to agarose gel electrophoresis (1%) to verify the integrity. An electrophoresis result image of the PCR amplification product identified by the gene knockout efficiency of channel catfish zbtb38 is shown in figure 4. Lane 9 is DNA Marker: from bottom to top, the gene sequence is 100bp, 250bp, 500bp, 750bp, 1000bp, 2000bp, 3000bp and 5000 bp. The first action is the electrophoresis result of the PCR amplification product of the sgRNA activity identification of the channel catfish zbtb38 gene even group; electrophoresis results of PCR amplification products of odd group sgRNA activity identification of channel catfish zbtb38 gene of the second behavior.
After the size of the PCR product is confirmed by electrophoresis, positive amplification products (8 selected) are sent to a commercial company for sequencing, and sequencing primers zbtb38-R1 have the following sequencing results:
even (2, 4, 6, 8) sgRNA groups: feeding back 8 sequencing results, wherein no obvious Indel mutation occurs, and a typical peak diagram is shown as CRISPR2 in a frame of FIG. 5); sgRNA odd groups (1, 3, 5, 7) group: 8 zbtb38-R1 sequencing results are fed back, 4 sequencing results in obvious Indel mutation nearby CRISPR7, and typical peaks are shown in FIG. 6.
After all sequencing results corresponding to sgRNA7, for which the editing activity was verified, were compared with the wild-type sequence (https:// tide. desktop. com /), the relative activity values were obtained, and the final activity rate was 3.562% by averaging. By combining the experimental results, the sgRNA7 synthesized by in vitro transcription by taking the zebra fish embryo as a reactor can effectively edit the channel catfish zbtb38 gene, and the activity is 3.562%. Concentrations suggested for use of the genome editing tool are: the working concentration of sgRNA (final concentration in the injection) was 100 ng/. mu. L, Cas9 protein at a final concentration of 250 ng/. mu.L.
The above description is only of the preferred embodiments of the present invention, and it should be noted that: it will be apparent to those skilled in the art that various modifications and adaptations can be made without departing from the principles of the invention and these are intended to be within the scope of the invention.
Sequence listing
<110> research institute for fresh water and aquatic products in Jiangsu province
<120> sgRNA sequence for targeted knockout of channel catfish zbtb38 gene and screening method thereof
<141> 2020-10-16
<160> 28
<170> SIPOSequenceListing 1.0
<210> 1
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 1
caatggtaac atcacagaac agg 23
<210> 2
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 2
tttgatgtcc tccacaacaa tgg 23
<210> 3
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 3
ccaagacatt tctgtgagca cgg 23
<210> 4
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 4
cagaggctgt gaaagcgttg cgg 23
<210> 5
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 5
ttgtggttcc agccaggtgc tgg 23
<210> 6
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 6
aacacctctg acttgagatc tgg 23
<210> 7
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 7
gtaaatgaaa ttaaggatgc tgg 23
<210> 8
<211> 23
<212> DNA/RNA
<213> Artificial Sequence
<400> 8
acttgctaaa tccactttgg agg 23
<210> 9
<211> 393
<212> DNA/RNA
<213> Artificial Sequence
<400> 9
atgatggtgg tccattccag ctgcaatggg atgatggaca acttgcaccc ccacactgtt 60
ctttctcgac tcagcgaaca acgatcactt ggcctgttct gtgatgttac cattgttgtg 120
gaggacatca aattccgtgc tcacagaaat gtcttggctg cgactagcgg atatttccgc 180
aacgctttca cagcctctga gacttgtggt tccagccagg tgctggaaat tccagatctc 240
aagtcagagg tgtttgccag catccttaat ttcatttact cctccaaagt ggatttagca 300
agtaaagggg acaacaagtc cttaatagct gcagggaaaa ggttagggat cccctttctt 360
gagaaacttc ttgagattga aaggcaagac tct 393
<210> 10
<211> 20
<212> DNA/RNA
<213> Artificial Sequence
<400> 10
caatgggatg atggacaact 20
<210> 11
<211> 20
<212> DNA/RNA
<213> Artificial Sequence
<400> 11
agtcttgcct ttcaatctca 20
<210> 12
<211> 59
<212> DNA/RNA
<213> Artificial Sequence
<400> 12
taatacgact cactataggc aatggtaaca tcacagaacg ttttagagct agaaatagc 59
<210> 13
<211> 59
<212> DNA/RNA
<213> Artificial Sequence
<400> 13
taatacgact cactataggt ttgatgtcct ccacaacaag ttttagagct agaaatagc 59
<210> 14
<211> 59
<212> DNA/RNA
<213> Artificial Sequence
<400> 14
taatacgact cactataggc caagacattt ctgtgagcag ttttagagct agaaatagc 59
<210> 15
<211> 59
<212> DNA/RNA
<213> Artificial Sequence
<400> 15
taatacgact cactataggc agaggctgtg aaagcgttgg ttttagagct agaaatagc 59
<210> 16
<211> 59
<212> DNA/RNA
<213> Artificial Sequence
<400> 16
taatacgact cactataggc agaggctgtg aaagcgttgg ttttagagct agaaatagc 59
<210> 17
<211> 59
<212> DNA/RNA
<213> Artificial Sequence
<400> 17
taatacgact cactatagga acacctctga cttgagatcg ttttagagct agaaatagc 59
<210> 18
<211> 57
<212> DNA/RNA
<213> Artificial Sequence
<400> 18
taatacgact cactatagta aatgaaatta aggatgcgtt ttagagctag aaatagc 57
<210> 19
<211> 59
<212> DNA/RNA
<213> Artificial Sequence
<400> 19
taatacgact cactatagga cttgctaaat ccactttggg ttttagagct agaaatagc 59
<210> 20
<211> 25
<212> DNA/RNA
<213> Artificial Sequence
<400> 20
aaaaaaagca ccgactcggt gccac 25
<210> 21
<211> 104
<212> DNA/RNA
<213> Artificial Sequence
<400> 21
gcaaugguaa caucacagaa cguuuuagag cuagaaauag caaguuaaaa uaaggcuagu 60
ccguuaucaa cuugaaaaag uggcaccgag ucggugcuuu uuuu 104
<210> 22
<211> 104
<212> DNA/RNA
<213> Artificial Sequence
<400> 22
guuugauguc cuccacaaca aguuuuagag cuagaaauag caaguuaaaa uaaggcuagu 60
ccguuaucaa cuugaaaaag uggcaccgag ucggugcuuu uuuu 104
<210> 23
<211> 104
<212> DNA/RNA
<213> Artificial Sequence
<400> 23
gccaagacau uucugugagc aguuuuagag cuagaaauag caaguuaaaa uaaggcuagu 60
ccguuaucaa cuugaaaaag uggcaccgag ucggugcuuu uuuu 104
<210> 24
<211> 104
<212> DNA/RNA
<213> Artificial Sequence
<400> 24
gcagaggcug ugaaagcguu gguuuuagag cuagaaauag caaguuaaaa uaaggcuagu 60
ccguuaucaa cuugaaaaag uggcaccgag ucggugcuuu uuuu 104
<210> 25
<211> 104
<212> DNA/RNA
<213> Artificial Sequence
<400> 25
guugugguuc cagccaggug cguuuuagag cuagaaauag caaguuaaaa uaaggcuagu 60
ccguuaucaa cuugaaaaag uggcaccgag ucggugcuuu uuuu 104
<210> 26
<211> 104
<212> DNA/RNA
<213> Artificial Sequence
<400> 26
gaacaccucu gacuugagau cguuuuagag cuagaaauag caaguuaaaa uaaggcuagu 60
ccguuaucaa cuugaaaaag uggcaccgag ucggugcuuu uuuu 104
<210> 27
<211> 102
<212> DNA/RNA
<213> Artificial Sequence
<400> 27
uaaaugaaau uaaggaugcg uuuuagagcu agaaauagca aguuaaaaua aggcuagucc 60
guuaucaacu ugaaaaagug gcaccgaguc ggugcuuuuu uu 102
<210> 28
<211> 104
<212> DNA/RNA
<213> Artificial Sequence
<400> 28
gacuugcuaa auccacuuug gguuuuagag cuagaaauag caaguuaaaa uaaggcuagu 60
ccguuaucaa cuugaaaaag uggcaccgag ucggugcuuu uuuu 104
Claims (8)
1. A screening method of sgRNA sequences for targeted knockout of channel catfish zbtb38 genes is characterized in that: comprises the steps of (a) preparing a mixture of a plurality of raw materials,
designing a CRISPR sequence which is shown as a sequence SEQ NO. 1-SEQ NO. 8;
preparing a PCR amplification product containing a target gene fragment by using the CRISPR sequence, wherein the target gene fragment is shown as a sequence SEQ NO. 9;
connecting the PCR amplification product containing the target gene fragment with a vector, transforming, screening positive transformants, cloning and shaking bacteria, and extracting a plasmid containing a target gene;
preparing sgRNA by an in vitro transcription method according to the designed CRISPR sequence;
and (3) microinjecting the sgRNA, the plasmid containing the target gene and the Cas9 protein into a fertilized egg of the zebra fish, and screening and editing the sgRNA sequence of the channel catfish zbtb38 gene by using the fertilized egg of the zebra fish as a reactor.
2. The method for screening sgRNA sequences for targeted knockout of ictalurus punctatus zbtb38 gene according to claim 1, wherein the method comprises: the CRISPR sequence is located 393bp before the exon of the zbtb38 gene.
3. The method for screening sgRNA sequences for targeted knockout of the channel catfish zbtb38 gene according to claim 1 or 2, wherein the method comprises: the sequence of the sgRNA comprises one or more of the sequences shown in SEQ NO. 21-SEQ NO. 28.
4. The method for screening sgRNA sequences for targeted knockout of ictalurus punctatus zbtb38 gene according to claim 1, wherein the method comprises: the sgRNA is prepared by an in vitro transcription method, and the used forward primer sequence comprises one or more of sequences SEQ NO. 12-SEQ NO. 19.
5. The method for screening sgRNA sequences for targeted knockout of the channel catfish zbtb38 gene according to any one of claims 1 to 2 and 4, wherein the method comprises the steps of: the plasmid containing the target gene is extracted by cloning and shaking the bacteria, and the used primer sequence comprises one or more than one of the sequences shown in SEQ NO.10 and SEQ NO. 11.
6. The method for screening sgRNA sequences for targeted knockout of ictalurus punctatus zbtb38 gene according to claim 5, wherein the method comprises: the plasmid containing the target gene is extracted by cloning and shaking the bacteria, and the used vector is pGEM-T Easy vector.
7. The method for screening sgRNA sequences for targeted knockout of ictalurus punctatus zbtb38 gene according to claim 1, wherein the method comprises: the microinjection is performed, wherein the final concentration of the sgRNA in the injection solution is 100 ng/mu L, and the final concentration of the Cas9 protein is 250 ng/mu L.
8. A sequence for targeted knockout of the channel catfish zbtb38 gene, characterized in that: comprises the steps of (a) preparing a mixture of a plurality of raw materials,
the CRISPR sequence is shown as a sequence SEQ NO. 7;
the primer comprises one or more than one of the sequences shown in SEQ NO. 10-SEQ NO. 20; and the number of the first and second groups,
the sgRNA sequence comprises one or more sequences shown in SEQ NO. 21-SEQ NO. 28.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011253224.5A CN112342214B (en) | 2020-11-11 | 2020-11-11 | sgRNA sequence of targeted knockout channel catfish zbtb38 gene and screening method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011253224.5A CN112342214B (en) | 2020-11-11 | 2020-11-11 | sgRNA sequence of targeted knockout channel catfish zbtb38 gene and screening method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112342214A true CN112342214A (en) | 2021-02-09 |
CN112342214B CN112342214B (en) | 2024-03-26 |
Family
ID=74363343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011253224.5A Active CN112342214B (en) | 2020-11-11 | 2020-11-11 | sgRNA sequence of targeted knockout channel catfish zbtb38 gene and screening method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112342214B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113186307A (en) * | 2021-06-21 | 2021-07-30 | 江苏省淡水水产研究所 | Sex-linked SNPs (single nucleotide polymorphisms) marker development method based on channel catfish male specific gene zbtb38-Y and application |
CN113373244A (en) * | 2021-07-14 | 2021-09-10 | 江苏省淡水水产研究所 | Method for rapidly detecting genetic sex of channel catfish based on SNP site-specific primer extension reaction |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109161603A (en) * | 2018-10-31 | 2019-01-08 | 江苏省淡水水产研究所 | The microsatellite marker primer and genetic sex identification method of channel catfish gunther sex-linked |
CN110904103A (en) * | 2019-10-18 | 2020-03-24 | 陕西师范大学 | Zebra fish mutant with GRNa gene knockout function and preparation method thereof |
CN111269943A (en) * | 2019-08-10 | 2020-06-12 | 湖南文理学院 | Method for increasing growth speed of zebra fish through gene knockout technology |
CN111926017A (en) * | 2020-08-27 | 2020-11-13 | 南开大学 | Preparation and application of csf1ra gene-deleted zebra fish mutant |
-
2020
- 2020-11-11 CN CN202011253224.5A patent/CN112342214B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109161603A (en) * | 2018-10-31 | 2019-01-08 | 江苏省淡水水产研究所 | The microsatellite marker primer and genetic sex identification method of channel catfish gunther sex-linked |
CN111269943A (en) * | 2019-08-10 | 2020-06-12 | 湖南文理学院 | Method for increasing growth speed of zebra fish through gene knockout technology |
CN110904103A (en) * | 2019-10-18 | 2020-03-24 | 陕西师范大学 | Zebra fish mutant with GRNa gene knockout function and preparation method thereof |
CN111926017A (en) * | 2020-08-27 | 2020-11-13 | 南开大学 | Preparation and application of csf1ra gene-deleted zebra fish mutant |
Non-Patent Citations (1)
Title |
---|
KARIM KHALIL等: "Generation of Myostatin Gene-Edited Channel Catfish (Ictalurus punctatus) via Zygote Injection of CRISPR/Cas9 System", 《SCIENTIFIC REPORTS》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113186307A (en) * | 2021-06-21 | 2021-07-30 | 江苏省淡水水产研究所 | Sex-linked SNPs (single nucleotide polymorphisms) marker development method based on channel catfish male specific gene zbtb38-Y and application |
CN113186307B (en) * | 2021-06-21 | 2023-08-01 | 江苏省淡水水产研究所 | Sex-linked SNPs (single nucleotide polymorphisms) marker development method and application based on channel catfish male specific gene zbtb38-Y |
CN113373244A (en) * | 2021-07-14 | 2021-09-10 | 江苏省淡水水产研究所 | Method for rapidly detecting genetic sex of channel catfish based on SNP site-specific primer extension reaction |
CN113373244B (en) * | 2021-07-14 | 2023-05-23 | 江苏省淡水水产研究所 | Method for rapidly detecting genetic sex of channel catfish based on SNP locus specific primer extension reaction |
Also Published As
Publication number | Publication date |
---|---|
CN112342214B (en) | 2024-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106282231B (en) | Construction method and application of mucopolysaccharide storage disease type II animal model | |
CN110541002A (en) | method for constructing zebra fish asap1b gene knockout mutant by using CRISPR/Cas9 technology | |
CN112342214B (en) | sgRNA sequence of targeted knockout channel catfish zbtb38 gene and screening method thereof | |
CN107267516B (en) | Double sgRNA mediated gene precise modification method and application | |
CN111154758A (en) | Method for knocking out zebra fish slc26a4 gene | |
CN114959066A (en) | Molecular marker influencing intramuscular fat content traits of pigs and application | |
CN107267627A (en) | The preparation and application of the Six1 gene molecule marker related to pig production character | |
CN113584079A (en) | Establishment of zebra fish heart specific marker strain applied to calcium ion imaging | |
CN101063169A (en) | PCR-RFLP method for checking goat luteotropin gene mononucleotide polymorphism | |
CN110894510A (en) | Method for breeding Lgr6 gene-deleted zebra fish through gene knockout | |
CN113817734A (en) | Hectd4 gene knockout zebra fish epilepsy model and construction method and application thereof | |
CN112342215B (en) | sgRNA sequence of targeted knockout channel catfish mstna gene and screening method thereof | |
CN106119407A (en) | LAP3 gene is as the molecular marker of ovine growth character and application thereof | |
CN114958857A (en) | Piggy gene knockout zebra fish neurodevelopment disorder model and construction method and application thereof | |
CN115058424A (en) | Irf2bpl gene knockout zebra fish epilepsy model and construction method and application thereof | |
CN116536327A (en) | Wheat yellow mosaic disease gene TaEIF4E and application thereof | |
CN115029352A (en) | Method for breeding adgrg1 gene-deleted zebra fish through gene knockout | |
CN113957070A (en) | Chd2 gene knockout zebra fish epilepsy model and construction method and application thereof | |
CN109485714B (en) | TLK protein and application thereof in shrimp and crab antiviral strain breeding | |
CN113897362A (en) | Scn1lab gene knockout zebra fish epilepsy model and construction method and application thereof | |
CN113897361A (en) | Eef1b2 gene knockout zebra fish epilepsy model and construction method and application thereof | |
CN113913530A (en) | Molecular marker related to sheep body height and application thereof | |
CN113897399A (en) | Scn1lab gene knockout zebra fish epilepsy model and application thereof | |
CN112695034A (en) | Preparation method of zebra fish with ApoE gene deletion | |
CN107287301B (en) | Molecular marking method for selecting goat growth character by nucleolar phosphoprotein gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |